HUBEI PROVINCE, CHINA -- (MARKET WIRE) -- May 30, 2007 -- Benda Pharmaceutical, Inc. (“Benda” or the “Company”) (OTCBB: BPMA), a China-based pharmaceutical company producing conventional and Traditional Chinese Medicines, as well as Genedicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer, announced today revenue and net income guidance along with an operational outlook for the full year ended December 31, 2007.
